NCT03685747View on ClinicalTrials.gov

Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

August 30, 2020

Study Completion Date

October 1, 2020

Conditions
Peritoneal Dialysis-associated Peritonitis
Interventions
DRUG

Vancomycin

Vancomycin one-time 20 mg/kg intraperitoneal dose.

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT03685747 - Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter